课题基金 / 基金详情

SYSTOLIC HYPERTENSION IN THE ELDERLY - II

SYSTOLIC HYPERTENSION IN THE ELDERLY - II
老年人收缩性高血压 - II
批准号:
3337445
负责人:
MERWYN R GREENLICK
金额:
$0.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-09-01 至 1985-12-31

项目摘要

项目成果

MERWYN R GREENLICK的其他基金

相关文献

中文摘要
翻译
研究对象为551例60岁以上孤立性收缩期高血压患者
英文摘要
A cohort of 551 persons over age 60 with isolated systolic hypertension was recruited in 1981 and 1982 for a pilot study to test the feasibility of a full scale trial of the effects of stepped care drug treatment on health. Funding for the pilot study will end in June 1984; although the initial goal has been achieved, several important new research questions have arisen, and there is the need for completing all the work that has begun. The proposed research has the following objectives: 1. To test the safety and efficacy of low dose diuretic treatment, with and without beta blocking drugs, in isolated systolic hypertension in the elderly. Specifically, what proportion of patients can be controlled with 12.5 mg of chorthalidone daily, and does the addition of metoprolol to chlorthalidone alter the level of blood pressure control or the prevalence of side effects? 2. To study for two added years a cohort of elderly patients with isolated systolic hypertension who have been followed closely for two years, receiving either stepped care treatment or placebo, in order to a) validate and extend the incidence estimates for morbidity; b) improve the methods for adverse event monitoring; c) extend the incidence estimates for behavioral dysfunction; and d) complete the development and testing of the distributed data system. 3. To analyze and report the results from the Systolic Hypertension in the Elderly Program pilot study, publishing the scientific findings and the methodological advances in clinical trial technology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OREGON NODE - NATIONAL CLINICAL TRIALS NETWORK
OREGON NODE - NATIONAL CLINICAL TRIALS NETWORK
OREGON NODE - NATIONAL CLINICAL TRIALS NETWORK
OREGON NODE - NATIONAL CLINICAL TRIALS NETWORK